Politis S.N., Rekkas D.M., Pelletization Processes for Pharmaceutical Applications: A Patent Review. Recent Patents on Drug Delivery and Formulation 5,1,61-78,2010.
Korakianiti E., Rekkas D.M, Statistical thinking and knowledge management for quality-driven design and manufacturing in pharmaceuticals.Pharmaceutical Research 28,1465-79,2011.
Politis S.N., Rekkas D.M., The Evolution of the manufacturing science and the pharmaceutical industry.Pharmaceutical Research 28,1779-1781,2011.
Politis S.N., Rekkas D.M. Recent advantages in pulsatile oral drug delivery systems. Recent Patents on Drug Delivery and Formulation 7,2,87-98,2013.
Belotti S., Rossi A., Colombo P., Bettini R., Rekkas D., Politis S., Colombo G.,Balducci AG., Buttini F., Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction.International Journal of Pharmaceutics 471,1-2,507-515,2014.
Belotti S., Rossi A., Colombo P., Bettini R., Rekkas D., Politis S., Colombo G., Balducci AG., Buttini F., Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation.European Journal of Pharmaceutics and Biopharmaceutics 93,165-172,2015.
Politis S.N, Colomblo P, Colombo G, Rekkas D.M. Design of experiments (DoE) in pharmaceutical development.Drug Development and Industrial Pharmacy 43,6,889-901,2017.
Karatzas AA, Politis SN, Rekkas DM.Development of rapidly dissolving pellets within the Quality by Design approach.Drug Development and Industrial Pharmacy 43,5,770-779,2017.
Politis S.N, Rekkas D.M.Development of a fast, lean and agile direct pelletization process using experimental design techniques. Drug Development and Industrial Pharmacy 43,4,545-557, 2017.
Buttini F, Rozou S, Rossi A, Zoumpliou V, Rekkas DM.,The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers. Eur J Pharm Sci. 2017 Nov 23. pii: S0928-0987(17)30618-8. doi:10.1016/j.ejps.2017.10.042.
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers, European Journal of Pharmaceutical Sciences, 2018,113, 64-76.
Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical stimulus, Biochimica et Biophysica Acta (BBA) - General Subjects, 2018, 1862, 9, 1913-1924.
Application of experimental design for the development of soft-capsules through a prilling, inverse gelation process. Journal of Drug Delivery Science and Technology. 2019, 49, 577-585.
Partial tablet coating by 3D printing. International Journal of Pharmaceutics, 2020,581,119298.
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems. Molecular Pharmaceutics, 2020, 17, 11, 4241–4255.
Preparation, characterization and pharmacokinetics of an inhalable dry powder formulation of a new hydrophobic antibiotic derivative for the treatment of lung infections. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 33, 2: April 2, 2020.
Δημήτριος Μ. Ρέκκας
Τομέας Φαρμακευτικής Τεχνολογίας
Τμήμα Φαρμακευτικής
Πανεπιστήμιο Αθηνών
Πανεπιστημιούπολη Ζωγράφου 15 771
Αθήνα
Τηλ: 210 727-4023, Fax: 210 727-4027
E-mail rekkas@pharm.uoa.gr